Snake venoms are formed by a complex mixture of active substances, mainly proteins, among these proteins; enzymes with phospholipase A 2 (PLA 2 ) activity are responsible for several biological effects, including neurotoxicity, edema, anticoagulant and myotoxic activities. The objective of this work was to purify and determined the anticoagulant and antithrombotic activity of a new PLA 2 (LmrTX) from Lachesis muta rhombeata venom. The protein was isolated by a combination of gel filtration and RP-HPLC on a C-5 Discovery® Bio Wide column. Molecular mass and homogeneity was determinate by ESI/MS. PLA 2 activity was determinate upon the chromogenic substrate 4-nitro-3-(octanoyloxy) benzoic acid. LmrTX was chemically modified using pbromophenacyl bromide (pBPB). Anticoagulat and antithrombotic activity was determinate using the Activated Partial Thromboplastin Time (APTT) and arterial thrombus induced photochemically assay, respectively. These activities were determinate for both native and modified enzyme. LmrTX was purified to homogeneity with a molecular mass of 14.243.50 Da, and a PLA 2 activity of 15.79 ± 0.18 nmol/min that was abrogated by chemical modification (1.73 ± 0.38 nmol/min). The PLA 2 prolonged the occlusion time (99 ± 10 min) when compare with the control (57 ± 7.8 min) at doses of 7.5 µg/mice and also prolonged the APTT time. Chemically modified LmrTX did not produce any effect in both experiments. We report a new basic PLA 2 purified from L. m. rhombeata snake venom that have an enzymatic-related antithrombotic and anticoagulant activities, that may play a relevant role in local and systemic bleeding that involves the Lachesis accidents.
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